Ciliary Body Melanoma
📧 Sign up to get email alerts when something new happens for Ciliary Body Melanoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-03-16Clinical Trial Update: Sunitinib Malate or Valproic Acid in Preventing Metastasis in Patients With High-Risk Uveal Melanoma [Phase 2]
Phase 2 clinical trial update evaluating sunitinib malate or valproic acid to prevent metastasis in high-risk uveal melanoma.
-
CLINICAL_TRIALS trial_result · 2025-08-06Clinical Trial Update: Transarterial Chemoembolization for the Treatment of Uveal Melanoma With Liver Metastases [Phase 2]
Phase 2 clinical trial update on transarterial chemoembolization for uveal melanoma with liver metastases; the study is currently active but…
-
CLINICAL_TRIALS trial_result · 2015-07-20Clinical Trial Update: Cixutumumab in Treating Patients With Metastatic Melanoma of the Eye [Phase 2]
Phase 2 trial update for cixutumumab in metastatic intraocular melanoma (ciliary body/choroid, iris) completed with posted results in 2015.
-
CLINICAL_TRIALS trial_result · 2014-05-22Clinical Trial Update: Vaccine Therapy in Treating Patients With Stage IIC-IV Melanoma [Phase 2]
A Phase 2 vaccine therapy trial in melanoma patients with Stage IIC to IV disease has completed. The trial encompassed intraocular subtypes …
-
CLINICAL_TRIALS trial_result · 2013-03-05Clinical Trial Update: Bortezomib, Paclitaxel, and Carboplatin in Treating Patients With Metastatic Melanoma [Phase 2]
A Phase 2 trial evaluating the combination of bortezomib, paclitaxel, and carboplatin in patients with metastatic and intraocular melanoma h…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2012-07-11Clinical Trial Update: Sorafenib, Carboplatin, and Paclitaxel in Treating Patients With Stage IV Melanoma of the Eye [Phase 2]
Phase 2 trial evaluating sorafenib in combination with carboplatin and paclitaxel for stage IV ocular melanoma has completed enrollment, wit…